Adamo Soft Capsule 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 capsule (0.5mg) once daily. Because exposure to the capsule contents may cause irritation of the oropharyngeal mucosa, swallow this medicine whole without chewing or breaking it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or elderly patients. The recommended dose of this medicine in patients with hepatic impairment has not been established because no data are available on its use in these patients.

This medicine can be absorbed through the skin, so pregnant women or women who may become pregnant should not handle this drug directly. If a capsule is broken and the medication comes into contact with skin, it must be washed off immediately with soap and water. Children should also be kept away from this drug, and if contacted, should be washed immediately. Women, children under 18 years, and those allergic to this drug or similar components should not take this medication. Men who are planning to conceive should discuss with their doctor, as this drug may affect reproductive ability. Caution is required when administering this drug to patients with poor urine flow or severe urinary symptoms, and symptoms of urinary retention should be closely monitored. Patients with impaired liver function should use this drug cautiously as it may remain in the body for a long time. Special attention is needed when taken alongside strong CYP3A4 enzyme inhibitors, as drug levels may increase. While taking this drug, side effects related to sexual function such as erectile dysfunction, decreased libido, and ejaculation disorders may occur, and these symptoms may persist after discontinuation. Additionally, gynecomastia and breast tenderness can occur, so any unusual symptoms should be reported to a healthcare professional. This drug is used for benign prostatic hyperplasia and male pattern hair loss and requires testing for prostate cancer both before and during treatment. This drug lowers PSA levels in the blood, necessitating caution in interpreting test results, and new reference values should be established within 3 to 6 months after administration. Regular prostate cancer screenings should be conducted while taking this medication, and any abnormalities should prompt immediate consultation with a healthcare provider. This drug may increase the risk of heart failure, so patients with heart disease should be particularly cautious. Blood donation is prohibited during this medication course and can only occur at least 6 months after the last dose. There is no specific antidote for overdose, so treatment should be given based on symptoms, and recovery may take time due to the long half-life of the drug. Store out of reach of children, and keep in the original container to prevent misuse or degradation of quality. This drug is known not to affect driving or operating machinery, but caution is advised as individual responses may vary. No significant interactions have been noted with various drugs; however, caution is required when used alongside specific medications, so consultation with a doctor or pharmacist is recommended.

• Erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This drug should be stored in a tightly sealed container that allows for good air circulation, and it is best to maintain the temperature below 30 degrees Celsius. Proper storage will help preserve the drug's effectiveness for a longer duration.

Appearance

A transparent yellow oval soft capsule containing a colorless transparent liquid

Package unit

30 capsules (15 capsules/PTPX2)